CSEIX
Price
$16.43
Change
-$0.01 (-0.06%)
Updated
Jul 8 closing price
Net Assets
8.09B
FIKJX
Price
$16.81
Change
-$0.05 (-0.30%)
Updated
Jul 8 closing price
Net Assets
186.77M
Interact to see
Advertisement

CSEIX vs FIKJX

Header iconCSEIX vs FIKJX Comparison
Open Charts CSEIX vs FIKJXBanner chart's image
Cohen & Steers Real Estate Securities A
Price$16.43
Change-$0.01 (-0.06%)
VolumeN/A
Net Assets8.09B
Fidelity Advisor Real Estate Z
Price$16.81
Change-$0.05 (-0.30%)
VolumeN/A
Net Assets186.77M
CSEIX vs FIKJX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CSEIX vs. FIKJX commentary
Jul 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSEIX is a Buy and FIKJX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CSEIX has more cash in the bank: 8.09B vs. FIKJX (187M). CSEIX pays higher dividends than FIKJX: CSEIX (2.47) vs FIKJX (2.09). CSEIX was incepted earlier than FIKJX: CSEIX (28 years) vs FIKJX (7 years). CSEIX (1.10) is less costly to investors than FIKJX (0.62). CSEIX is a more actively managed with annual turnover of: 35.00 vs. FIKJX (24.00). CSEIX (0) and FIKJX (0) have matching initial minimum investment requirements. CSEIX annual gain was more profitable for investors over the last year : 9.82 vs. FIKJX (4.28). CSEIX return over 5 years is better than : 38.61 vs. FIKJX (-0.59).
CSEIXFIKJXCSEIX / FIKJX
Total Expense Ratio1.100.62177%
Annual Report Gross Expense Ratio1.100.62177%
Fund Existence28 years7 years-
Gain YTD3.9391.473267%
Front Load5%N/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets8.09B187M4,326%
Annual Yield % from dividends2.472.09119%
Returns for 1 year9.824.28230%
Returns for 3 years11.23-13.16-85%
Returns for 5 years38.61-0.59-6,579%
Returns for 10 years61.13N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LSSNX29.00N/A
N/A
Loomis Sayles Small Cap Growth N
PRHSX76.46N/A
N/A
T. Rowe Price Health Sciences
WPSGX56.24N/A
N/A
AB Concentrated Growth Advisor
IVKSX22.50N/A
N/A
VY® Invesco Comstock S
UAPIX62.18N/A
N/A
ProFunds UltraSmall Cap Inv